Related Experiment Video

Updated: Jan 17, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.3K

Colorectal carcinoma with sarcomatoid component: isolated SMARCA2 loss and high PD-L1 expression as a potential

Furkan Aknar1, Tuce Soylemez-Akkurt1, Huseyin Karatay2

  • 1Department of Pathology, Istanbul Medeniyet University, Istanbul, Türkiye.

Histopathology
|September 22, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
PD‐L1SMARCA2 losssarcomatoid colorectal carcinoma

More Related Videos

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.8K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K